{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:10:42Z","timestamp":1649027442497},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s11892-007-0054-y","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T07:13:29Z","timestamp":1191395609000},"page":"329-332","source":"Crossref","is-referenced-by-count":0,"title":["Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers"],"prefix":"10.1007","volume":"7","author":[{"given":"Anthony L.","family":"McCall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,4]]},"reference":[{"key":"54_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"W.C. Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393\u2013403.","journal-title":"N Engl J Med"},{"key":"54_CR2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J. Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343\u20131350.","journal-title":"N Engl J Med"},{"key":"54_CR3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","volume":"368","author":"J. Lindstrom","year":"2006","unstructured":"Lindstrom J, Ilanne-Parikka P, Peltonen M, et al.: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673\u20131679.","journal-title":"Lancet"},{"key":"54_CR4","doi-asserted-by":"crossref","unstructured":"Efect of intensive blood-glucose control with metformin on complications in over weight patients with type 2 diabetes (UKPDS 34). United Kingdom Prospective Diabetes Study Group [no authors listed]. Lancet 1998, 352:854\u2013865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"54_CR5","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). United Kingdom Prospective Diabetes Study Group [no authors listed]. Lancet 1998, 352:827\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"54_CR6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L. Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755\u20131762.","journal-title":"Lancet"},{"key":"54_CR7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diacare.28.4.942","volume":"28","author":"R. Vettor","year":"2005","unstructured":"Vettor R, Serra R, Fabris R, et al.: Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies. Diabetes Care 2005, 28:942\u2013949.","journal-title":"Diabetes Care"},{"key":"54_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.26.1.125","volume":"26","author":"S.J. McNulty","year":"2003","unstructured":"McNulty SJ, Ur E, Williams G: A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. Diabetes Care 2003, 26:125\u2013131.","journal-title":"Diabetes Care"},{"key":"54_CR9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1464-5491.2004.01474.x","volume":"22","author":"C. Berne","year":"2005","unstructured":"Berne C: A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin. Diabet Med 2005, 22:612\u2013618.","journal-title":"Diabet Med"},{"key":"54_CR10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/CIRCULATIONAHA.105.596130","volume":"114","author":"D.M. Gadde","year":"2006","unstructured":"Gadde DM, Allison DB: Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Circulation 2006, 114:974\u2013984.","journal-title":"Circulation"},{"key":"54_CR11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","volume":"113","author":"J.D. Otvos","year":"2006","unstructured":"Otvos JD, Collins D, Freedman DS, et al.: LDL and HDL particle subclasses predict coronary events and are changed favorably by gemfibrozil therapy in the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2006, 113:1556\u20131563.","journal-title":"Circulation"},{"key":"54_CR12","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"S.E. Nissen","year":"2007","unstructured":"Nissen SE, Wolski K: Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457\u20132471.","journal-title":"N Engl J Med"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-007-0054-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-007-0054-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-007-0054-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:18Z","timestamp":1559433378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-007-0054-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s11892-007-0054-y","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}